Screener
Core Scientific, Inc. CORZ Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Core Scientific, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.
The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 7:08 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001839341-26-000014
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total Current Liabilities | 2,737,794 | 781,401 |
| Long-term debt | 4,297,967 | 1,060,325 |
| Warrant liabilities, net of current portion | 163,683 | 936,107 |
| Deferred revenue, net of current portion | 367,242 | 428,290 |
| Other noncurrent liabilities | 110,163 | 104,261 |
| Total Liabilities | 7,676,849 | 3,310,384 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ Deficit: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Core Scientific, Inc.'s deferred revenue?
- Core Scientific, Inc. (CORZ) reported deferred revenue of $367.24M in Q2 2026.
- What is the long-term trend for Core Scientific, Inc.'s deferred revenue?
- Over 3 years (2021 to 2025), Core Scientific, Inc.'s deferred revenue has grown at a 106.2% compound annual growth rate (CAGR), from $63.42M to $555.85M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Core Scientific, Inc.'s deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude